The

The

acquisition of Dotmatics strengthens Siemens’ position as a global leader in

收购Dotmatics加强了西门子作为全球领导者的地位

AI-powered PLM software and enables Siemens to

AI驱动的PLM软件，使西门子能够

scale its technologies into Life Sciences to fully address growth opportunities

将技术扩展到生命科学领域，以全面把握增长机遇

in this market. Dotmatics’ Scientific Intelligence Platform,

在这个市场中，Dotmatics的科学智能平台，

Luma, and its industry-leading scientific applications enable AI-powered

Luma及其行业领先的科学应用使人工智能赋能

multi-modal drug development, seamless collaboration, and contextualized data creating

多模态药物开发、无缝协作和情境化数据创建

a connected digital thread across the research-to-production value chain.

跨越研发到生产价值链的互联数字主线。

“With

“随着

Dotmatics, we’re building a new era of innovation in Life Sciences. From

Dotmatics，我们正在生命科学领域开创一个创新的新时代。从

research through to production – we’re creating a unique, end-to-end digital

从研究到生产——我们正在创建一个独特的、端到端的数字

thread: We combine Dotmatics’ scientific intelligence with our industrial AI

线程：我们将Dotmatics的科学智能与我们的工业AI相结合

technologies and digital twins,” said Roland Busch, President and CEO of

“技术和数字孪生，”罗兰·布希，总裁兼首席执行官表示

Siemens AG. “This will allow us to help our customers accelerate breakthroughs,

西门子股份公司：“这将使我们能够帮助客户加快突破，

reduce development cycles, and bring life-saving pharmaceuticals faster and

缩短开发周期，更快地带来拯救生命的药物

more affordably to the market.”

更实惠地进入市场。”

This

这

transaction expands Siemens’ total addressable market for industrial software

该交易扩大了西门子在工业软件领域的总可寻址市场。

by $11 billion and aligns with ‘ONE Tech Company’, the company’s strategic

110亿美元，并与“ONE Tech Company”（公司战略）保持一致，

growth program, aimed at accelerating innovation and creating value across

增长计划，旨在加速创新并在各个领域创造价值

industries. Dotmatics is expected to generate more than $300 million in revenue

行业。Dotmatics预计收入将超过3亿美元

in fiscal year 2025 with an adjusted EBITDA margin above 40 percent, further

在2025财年，调整后的息税折旧摊销前利润率超过40%，进一步

enhancing Siemens’ growth profile. Dotmatics’ revenue growth and high

增强西门子的增长前景。Dotmatics的收入增长和高

profitability will be immediately accretive to Siemens’ growth, EBITDA margins

盈利能力将立即促进西门子的增长和EBITDA利润率。

and free cash flow, prior to any synergies and special items. Siemens expects

以及在任何协同效应和特殊项目之前的自由现金流。西门子预计

substantial revenue synergies: Medium-term revenue synergies expected of around

可观的收入协同效应：预计中期收入协同效应约为

$100 million per year accelerating to over $500 million per year in the

每年 1 亿美元，加速至每年超过 5 亿美元

long-term.

长期的。